Le Lézard
Classified in: Health
Subjects: MAV, FVT, CFG

Media Advisory - Minister Wilson-Raybould to announce major investment in leading-edge genomics and precision health research in British Columbia


VANCOUVER, Jan. 22, 2018 /CNW/ - The Honourable Jody Wilson-Raybould, Minister of Justice and Attorney General of Canada, on behalf of the Honourable Kirsty Duncan, Minister of Science, will announce investments being made through two of Genome Canada's premier funding programs. The investments will help some of British Columbia's leading scientists advance genomics and precision health research that lead to new medical therapies to improve the health and well-being of Canadians.

 

Date:

Tuesday, January 23, 2018



Time:

10:00 a.m.



Location:

BC Children's Hospital Research Institute


938 W 28th Avenue


Vancouver, British Columbia

 

The main entrance is directly across from the north entrance to BC Children's Hospital.

 


SOURCE Innovation, Science and Economic Development Canada


These press releases may also interest you

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31,...

at 16:20
AN2 Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the fourth quarter and year ended...

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that its Board of Directors has unanimously approved plans to initiate a rights offering. The...

at 16:19
Aflac Incorporated announced today that it will release first quarter 2024 financial results after the market closes on May 1, 2024. At that time, earnings materials, including the quarterly earnings release and financial supplement, will be...

at 16:15
Medpace Holdings, Inc. ("Medpace") today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024,...

at 16:15
  Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic Non-Small Cell...



News published on and distributed by: